Photo of Jonathan Shamay-Draluck

Jonathan Shamay-Draluck

Jonathan Shamay-Draluck is a seasoned transactional attorney who has led complex, high-value arrangements on behalf of, or opposite, dozens of Fortune 100 companies.

With a particular focus on the rapidly growing digital infrastructure industry, Jonathan has represented investors, hyperscalers, developers and others in data center construction, leasing, and the full range of ancillary commercial arrangements. He has also negotiated deployment of subsea and terrestrial fiber and supported operation of data network elements around the globe.

But his broad technology practice has brought him to serve in a variety of roles including as outside and in-house counsel to technology companies and IT consulting firms, leading efforts to align proprietary offerings, professional services and third-party systems, helping them to enable enterprises to leverage AI and other high-throughput platforms.

Extending his transactional capabilities beyond the technology sector Jonathan has represented pharmaceutical and medical device companies as they negotiated M&A, sponsored research, clinical trials, technology transfer, patent licensing, and manufacture agreements. He also counsels startups on formation, securities issuance, intellectual property protection, compliance, go-to-market contracting, and sale of control.

A solar water heater on every Israeli rooftop
A solar water heater on every Israeli rooftop

Israel is a garden of inventiveness and Israelis have a strong tradition of contributing to technology and life sciences. Breathing the innovation when I lived there, I was privileged to test PrimeSense’s 3D camera, help bring Notal Vision’s tool to gauge macular degeneration to the United States, deliver a turn-key VoIP network in Nigeria and Zambia on behalf of VocalTec, license ecommerce and security software to dozens of Fortune 100 companies, watch knee surgery with miraculous tissue-repairing Regentis hydrogel, play with a gear box created from an Objet (now Stratasys) 3D printer, and negotiate sponsored research, patent licenses and clinical trials on behalf of emerging pharmaceutical companies.

Figuring out what gives rise to the “start-up nation” character, with wildly disproportionate foreign direct investment and numbers of translated books, cited academics, filed patents, Nasdaq companies, successful exits, and tuneful children’s songs, is a pervasive new-age question. Many answers have been floated, including its world-class research institutions, the very first technology transfer offices for commercialization of academic R&D, raw skills honed in one of the best-trained and most-sophisticated militaries, a culture of questioning, and a flood of ex-Soviet engineering talent over three decades. Naturally one can’t discount that there are real issues to be addressed too. Israelis have done it — from discerning security risks through synthesis of big data to making the desert bloom with fruit, vegetables, fish, and minerals.
Continue Reading Ingenuity in Israel’s Water